Showing results (1641-1650 of 4,056) with videos related to

Sort By:
Pageof 406
Translational Cancer Research|February 12, 2026
Prognostic value of palmitoylation-regulated mechanisms in glioblastoma: integrated multi-omics analysis via least absolute shrinkage and selection operator (LASSO) regression and single-cell sequencingYujie Ji, Xiangyu Dai, Lei Jiang, et al.
Translational Cancer Research|February 12, 2026
Evaluation of parietal pleural invasion in subpleural lung cancer by VEGFR2 targeted microbubble-based ultrasound molecular imagingShiyu Zhang, Yuxin Zhang, Dian Tao, et al.
Translational Cancer Research|February 12, 2026
Temporal-spatial evolution of tumor habitat analysis: a bibliometric study on research hotspots and trends in medical imaging (2014-2025)Xuanle Li, Yongde Guo, Shichen Xu, et al.
Translational Cancer Research|February 12, 2026
Tumor microenvironment-guided targeted and immunotherapy in anaplastic thyroid cancer: a literature review from preclinical models to clinical translationHong Kang, Shizhen Wu, Hao Gong, et al.
Translational Cancer Research|February 12, 2026
VDAC1 and VDAC2 as prognostic biomarkers and therapeutic targets in hepatocellular carcinomaYujie Deng, Runmin Long, Meng Tang, et al.
Translational Cancer Research|October 29, 2025
Constructing a chemokine-based model and identifying CCL17 as a core biomarker associated with immune infiltrates in thyroid cancerMimi Zhang, Bing Zou, Qiang Li, et al.
Translational Cancer Research|October 29, 2025
Neochlorogenic acid inhibits gastric cancer cell growth through apoptosis and cell cycle arrestWenqiang Sun, Yongchao Li, Menglong Xu, et al.
Translational Cancer Research|October 29, 2025
Real-time prognosis prediction with conditional survival analysis for skull base chordoma based on SEERXiaojia Zhang, Xiaosheng Chen, Jiajie Gu
Translational Cancer Research|October 29, 2025
Prognostic difference of single metastasis in different sites of hepatocellular carcinoma: a population-based studyYingjie Zhuang, Qing Chang, Wenhui Liu, et al.
Translational Cancer Research|October 29, 2025
B3GNT3 is an oncogenic and prognostic biomarker in human tumors via pan-cancer analysis combined with experimental validationKe Shen, Xinhuai Dong, Chong Zeng, et al.
Pageof 406